drugset / Trial / NCT00109083
A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to evaluate whether RWJ-333369 is a safe and effective treatment in reducing the number of migraine headaches when added to a person's usual medications for acute migraine headache relief.
Timeline
- Start
- 2002-03
- Primary completion
- 2006-02
- Completion
- 2006-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carisbamate | Small molecule | 100 mg | — |
| Subject | Carisbamate | Small molecule | 300 mg | — |
| Subject | Carisbamate | Small molecule | 600 mg | — |